Trametinib - Novartis
At a glance
- Drug Originator Japan Tobacco
- Drug Licenced by BeiGene; Novartis
- Drug Class 2 ring heterocyclic compounds; Amides; Antidementias; Antineoplastics; Cyclopropanes; Fluorobenzenes; Iodobenzenes; Pyridines; Pyrimidines; Small molecules
- Mechanism of Action MAP kinase kinase 1 inhibitors; MAP kinase kinase 2 inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 9
- NDAs 2
- International Patents 169
- Patent Applications 2,448
Table of Contents
Disclaimer